Sun Pharma Advanced Research Company fundamental analysis

SPARC

221.35

14.22 (-6.04%)
Last updated on 27 May, 2026 | 15:51 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Sun Pharma Advanced Research Company Fundamentals

P/E Ratio

4.9

P/B Ratio

5.69

Div. Yield

0

Sector P/E

24.73

Sector P/B

2.87

Sec. Div. Yield

1.39

Sun Pharma Advanced Research Company Fundamentals is currently trading with a P/E Ratio of 4.9, compared to the sector average of 24.73. Its P/B Ratio stands at 5.69, while the sector’s is 2.87. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 1.39%.

Sun Pharma Advanced Research Company Score Card

  • price_icon
    Price

    Attractive

  • chart_icon
    Growth

    Good

  • quality_check
    Quality

    Poor

  • quality_check
    Management

    Poor

On its scorecard, Sun Pharma Advanced Research Company reflects: Price – Attractive, Growth – Good, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost